Starting together: A focus group for the organization of a CKD outpatient care unit

Journal of Nephrology

Volumn 23, Issue 6, 2010, Pages 699-704

  Piccoli, Giorgina B ^a   Consiglio, Valentina ^a   Deagostini, Maria C ^a   Manente, Elisa ^a   Scarpa, Roberto M ^a  

^a SAN LUIGI GONZAGA UNIVERSITY HOSPITAL   (Italy)

Author keywords

CKD; Continuity of care; Focus groups; Patient physician relationship; Quality of care; Quality of life

Indexed keywords

ADAPTIVE BEHAVIOR; ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONSULTATION; CRITICAL ILLNESS; DAILY LIFE ACTIVITY; DIALYSIS; DISEASE DURATION; DOCTOR PATIENT RELATION; FEMALE; HEALTH CARE FACILITY; HEALTH CARE NEED; HEALTH CARE ORGANIZATION; HUMAN; KIDNEY TRANSPLANTATION; LONG TERM CARE; MALE; OUTPATIENT CARE; PATIENT ATTITUDE; PATIENT CARE; PATIENT DECISION MAKING; PATIENT EDUCATION; RECORDING; SUPPORT GROUP;

ADULT; AGED; AMBULATORY CARE; CHRONIC DISEASE; FEMALE; FOCUS GROUPS; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 78549288178     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Rocco M. Disease management programs for CKD patients: the potential and pitfalls. Am J Kidney Dis. 2009;53(Suppl 3):S56-S63.
2. Rutkowski M, Mann W, Derose S, et al. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente. Am J Kidney Dis. 2009;53(Suppl 3):S86-S99.
3. Thorp ML, Weinstein JR, Johnson ES, Yang X, Smith DH. Secular trends in kidney disease: is the decreased incidence of renal replacement therapy due to a decrease in chronic kidney disease incidence? Clin Nephrol. 2008;70:187-193.
4. Calderon JL, Fleming E, Gannon MR, Chen SC, Vassalotti JA, Norris KC. Applying an expanded set of cognitive design principles to formatting the Kidney Early Evaluation Program (KEEP) longitudinal survey. Am J Kidney Dis. 2008;51(Suppl 2):S83-S92. (Pubitemid 351417313)
5. Hutchinson TA. The price and challenges of extraordinary success: treating end-stage renal failure in the next millennium. CMAJ. 1999;160:1589-1590.
6. Crooks P. International care models for chronic kidney disease: methods and economics - United States. Blood Purif. 2004;22:13-20. (Pubitemid 38142284)
7. Fukuhara S, Yamazaki C, Hayashino Y, et al. The organization and financing of end-stage renal disease treatment in Japan. Int J Health Care Finance Econ. 2007;7:217-231.
8. Harris A. The organization and funding of the treatment of end-stage renal disease in Australia. Int J Health Care Finance Econ. 2007;7:113-132.
9. Locatelli F, Zoccali C; SIR SIN Study Investigators. Clinical policies on the management of chronic kidney disease patients in Italy. Nephrol Dial Transplant. 2008;23:621-626.
10. Shyam C, Dakshina Murty KV, Sreenivas V, Ram R. Chronic kidney disease: need for a national action plan. Indian J Med Res. 2007;125:498-501. (Pubitemid 47099103)
11. Kuo HW, Tsai SS, Tiao MM, Yang CY. Management of chronic kidney disease in Taiwan: room for quality improvement. J Nephrol. 2009;22:654-661.
12. Kolewaski CD, Yeates K. Chronic kidney disease among indigenous populations: considerations for effective and ethical research. J Nephrol. 2009;22:571-579.
13. Quintaliani G, Cappelli G, Lodetti L, et al. Chronic Kidney Disease Certification process manual by the Italian Society of Nephrology (SIN) part I: Clinical care delivery and performance care and improvement. J Nephrol. 2009;22:423-438.
14. Quintaliani G, Cappelli G, Lodetti L, et al. Chronic Kidney Disease Certification process manual by the Italian Society of Nephrology (SIN) part II: programme management and clinical information amnagement. J Nephrol. 2009;22:565-570.
15. Available at: http://en.wikipedia.org/wiki/Managed-care. Accessed August 10, 2009.
16. Laliberte F, Bookhart BK, Vekeman F, et al. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective. J Manag Care Pharm. 2009;15:312-322.
17. Bodenheimer T. Disease management in the American market. BMJ. 2000;320:563-566.
18. Mattke S, Seid M, Ma S. Evidence for the effect of disease management: is $1 billion a year a good investment? Am J Manag Care. 2007;13:670-676.
19. Perlman RL, Finkelstein FO, Liu L, et al. Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis. 2005;45:658-666.
20. Cohen SD, Patel SS, Khetpal P, Peterson RA, Kimmel PL. Pain, sleep disturbance, and quality of life in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2007; 2: 919-925.
21. Devine EB, Smith KL, Stehman-Breen C, Patrick DL. Health-related quality of life assessment in chronic kidney disease. Expert Rev Pharmacoecon Outcomes Res. 2003; 3: 89-100. (Pubitemid 36204457)
22. Leung F, Ratnapalan S. Spotlight on focus groups. Can Fam Physician. 2009; 55: 218-219.
23. Asbury J. Overview of focus group research. Qual Health Res. 1995;5:414-420.
24. Kevern J, Webb C. Focus groups as a tool for critical social research in nurse education. Nurse Educ Today. 2001;21:323-333. (Pubitemid 33669001)
25. Barbour RS. Making sense of focus groups. Med Educ. 2005;39:742-750.
26. Bass EB, Jenckes MW, Fink NE, et al. Use of Focus Groups to Identify Concerns about Dialysis. Med Decis Making. 1999;19:287-295. (Pubitemid 29321270)
27. Piccoli GB, Mereu C, Sanfilippo R, et al. Life without quality. Reflections of a female focus group on life, health and kidney disease. J Nephrol. 2008;21(Suppl 13):S124-S128.
28. Luft HS. Health care reform - Toward more freedom, and responsibility, for physicians. N Engl J Med. 2009;361:623-628.